• Home

  • Documents

  • nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose...
7

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 2: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 3: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 4: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 5: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 6: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration
Page 7: nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/75/ribavirinduration and dose ...depts.washington.edu/hepstudy/presentations/uploads/75/... · 2014-02-18 · Treatment Duration

CFOA UwFS Protocol Code of Practice v2

CFOA UwFS Protocol Code of Practice v2

Documents
ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,

Documents
nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117

nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/117

Documents
Treatment of HCV in Patients with HIV Coinfectiondepts.washington.edu/hepstudy/presentations/... · HCV/HIV co-infected versus HCV monoinfection (P

Treatment of HCV in Patients with HIV Coinfectiondepts.washington.edu/hepstudy/presentations/... · HCV/HIV co-infected versus HCV monoinfection (P

Documents
Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015  · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•

Ombitasvir-Paritaprevir-Ritonavir (Techniviedepts.washington.edu/hepstudy/presentations/uploads/161/technivie... · 16/12/2015  · Ombitasvir-Paritaprevir-Ritonavir (Technivie)•

Documents
Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir

Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir Viekira …depts.washington.edu/hepstudy/presentations/uploads/131/...Hepatitis web study Ombitasvir-Paritaprevir-Ritonavir + Dasabuvir

Documents
Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/57/quest1.pdfQUEST-1 Trial QUEST-1 Trial: Features Design: Randomized, double-blind,

Documents
Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure

Documents
Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein, DB et al Ann Intern Med 2012:156:263-70. web study HCV Testing of Persons Born

Documents
nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/102/nnrti …depts.washington.edu/nwaetc/presentations/uploads/102/... · 2013. 6. 3. · Case #4 A 45-year-old woman presents

nfs/bronfs/uwfs/hw00/d99/nwaetc/presentations/uploads/102/nnrti …depts.washington.edu/nwaetc/presentations/uploads/102/... · 2013. 6. 3. · Case #4 A 45-year-old woman presents

Documents
Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1 … › hepstudy › presentations › ...Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 A1444040 Trial

Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1 … › hepstudy › presentations › ...Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 A1444040 Trial

Documents
Counseling Patients With Chronic Hepatitis C Virus Infectiondepts.washington.edu/hepstudy/presentations/uploads/26/m...Debika Bhattacharya, MD, MSc Assistant Professor of Medicine

Counseling Patients With Chronic Hepatitis C Virus Infectiondepts.washington.edu/hepstudy/presentations/uploads/26/m...Debika Bhattacharya, MD, MSc Assistant Professor of Medicine

Documents
Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis

Documents
Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment

Documents
Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced

Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced

Documents
nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/5 ...depts.washington.edu/hepstudy/presentations/... · Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, 1999-2007

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/5 ...depts.washington.edu/hepstudy/presentations/... · Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, 1999-2007

Documents
Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase

Documents
Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina

Acute Hepatitis C Virus Infection: Epidemiology, Clinical ...depts.washington.edu/hepstudy/presentations/uploads/6/m1_l5acute_hep_c.pdfHepatitis web study HEPATITIS WEB STUDY H. Nina

Documents
nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… · web study . Twice Daily Telaprevir for

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/52/optimizedepts.washington.edu/hepstudy/presentations/uploads/52/optimize.p… · web study . Twice Daily Telaprevir for

Documents
nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve

nfs/aesop01/hw00/d44/hepstudy/presentations/uploads/1 ...depts.washington.edu › ... › 1 › test_presentation.pdf · o ute ravr: umma o e tu ies Phase 2a Trial in Treatment Naïve

Documents
nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous

nfs/bronfs/uwfs/hw00/d44/hepstudy/presentations/uploads/41/best of …depts.washington.edu/hepstudy/presentations/uploads/41/... · 2013. 9. 25. · some portal areas Stage 2: Fibrous

Documents
State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant

State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant

Documents
Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve

Treatment Naïve - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/81/...Source: Manns M, et al. Lancet. 2014;384:414-26. Simeprevir + PEG + RBV in Treatment-Naïve

Documents
Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Addressing Psychiatric Issues Prior to HCV Treatmentdepts.washington.edu/hepstudy/presentations/uploads/35/m4_l3... · Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L,

Documents
Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT

Sofosbuvir in Genotypes 2 or 3 VALENCE Trialdepts.washington.edu/hepstudy/presentations/uploads/93/valence.pdf · Sofosbuvir and Ribavirin for HCV GT 2 or 3 VALENCE: Results for GT

Documents
Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness

Treatment of Chronic HCV Genotype 5 or 6depts.washington.edu/hepstudy/presentations/uploads/126/m5_l5... · • Decompensated hepatic disease • Major uncontrolled depressive illness

Documents